Primary cutaneous cryptococcosis in an immunocompetent patient due to Cryptococcus gattii molecular type VGI in Brazil: A case report and review of literature

Mycoses

Volumn 57, Issue 7, 2014, Pages 442-447

  Nascimento, Erika ^a   Bonifácio da Silva, Maria Emília Nadaletto ^a   Martinez, Roberto ^a   Von Zeska Kress, Marcia Regina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antifungal therapy; Cryptococcus gattii; Immunocompetent patient; Molecular type VGI; Primary cutaneous cryptococcosis PCC; Virulence factors

Indexed keywords

FLUCONAZOLE;

AGED; ARTICLE; BRAZIL; CASE REPORT; CRYPTOCOCCUS GATTII; CUTANEOUS CRYPTOCOCCOSIS; FUNGAL MATING TYPE GENE; FUNGUS IDENTIFICATION; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; LUNG EMPHYSEMA; MALE; MOLECULAR TYPING; PERIODIC ACID SCHIFF STAIN; POLYMERASE CHAIN REACTION; PRIMARY CUTANEOUS CRYPTOCOCCOSIS; PRIORITY JOURNAL; SERODIAGNOSIS; SKIN BIOPSY; CLASSIFICATION; CRYPTOCOCCOSIS; IMMUNOCOMPETENCE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY;

CRYPTOCOCCUS GATTII; FILOBASIDIELLA NEOFORMANS;

AGED; BRAZIL; CRYPTOCOCCOSIS; CRYPTOCOCCUS GATTII; HUMANS; IMMUNOCOMPETENCE; MALE;

EID: 84903123662     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12176     Document Type: Article

References (56)

1. Neuville S, Dromer F, Morin O, Dupont B, Ronin O, Lortholary O. Primary cutaneous cryptococcosis: a distinct clinical entity. Clin Infect Dis 2003; 36: 337-47. doi:10.1086/345956.
2. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515-48.
3. Kwon-Chung KJ, Bennett JE. High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl Bakteriol Mikrobiol Hyg A 1984; 257: 213-8.
4. Ellis DH, Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 1990; 28: 1642-4.
5. MacDougall L, Kidd SE, Galanis E et al. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest. USA. Emerg Infect Dis 2007; 13: 42-50. doi:10.3201/eid1301.060827.
6. Byrnes EJ III, Marr KA. The Outbreak of Cryptococcus gattii in Western North America: Epidemiology and Clinical Issues. Curr Infect Dis Rep 2011; 13: 256-61. doi:10.1007/s11908-011-0181-0.
7. Marr KA. Cryptococcus gattii as an important fungal pathogen of western North America. Expert Rev Anti Infect Ther 2012; 10: 637-43. doi:10.1586/eri.12.48.
8. Iatta R, Hagen F, Fico C, Lopatriello N, Boekhout T, Montagna MT. Cryptococcus gattii infection in an immunocompetent patient from Southern Italy. Mycopathologia 2012; 174: 87-92. doi:10.1007/s11046-011-9493-8.
9. Meyer W, Aanensen DM, Boekhout T et al. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 2009; 47: 561-70. doi:10.1080/13693780902953886.
10. Meyer W, Marszewska K, Amirmostofian M et al. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA-a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis 1999; 20: 1790-9. doi:10.1002/(SICI)1522-2683(19990101)20:8%3c1790:AID-ELPS1790%3e3.0.CO;2-2.
11. Litvintseva AP, Thakur R, Vilgalys R, Mitchell TG. Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics 2006; 172: 2223-38. doi:10.1534/genetics.105.046672
12. Meyer W, Castaneda A, Jackson S, Huynh M, Castaneda E. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 2003; 9: 189-95. doi:10.3201/eid0902.020246.
13. Kwon-Chung KJ. A new genus, filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia 1975; 67: 1197-200.
14. Kwon-Chung KJ. Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia 1976; 68: 821-33.
15. Chowdhary A, Randhawa HS, Boekhout T, Hagen F, Klaassen CH, Meis JF. Temperate climate niche for Cryptococcus gattii in Northern Europe. Emerg Infect Dis 2012; 18: 172-4. doi:10.3201/eid1801.111190.
16. Moore TD, Edman JC. The alpha-mating type locus of Cryptococcus neoformans contains a peptide pheromone gene. Mol Cell Biol 1993; 13: 1962-70.
17. Halliday CL, Bui T, Krockenberger M, Malik R, Ellis DH, Carter DA. Presence of alpha and a mating types in environmental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia. J Clin Microbiol 1999; 37: 2920-6.
18. Pau M, Lallai C, Aste N, Atzori L. Primary cutaneous cryptococcosis in an immunocompetent host. Mycoses 2010; 53: 256-8. doi:10.1111/j.1439-0507.2009.01707.x.
19. Rhodes JC, Polacheck I, Kwon-Chung KJ. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect Immun 1982; 36: 1175-84.
20. Salas SD, Bennett JE, Kwon-Chung KJ, Perfect JR, Williamson PR. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med 1996; 184: 377-86.
21. Innis MA. PCR protocols: a guide to methods and applications. San Diego: Academic Press, 1990.
22. Lin X, Nielsen K, Patel S, Heitman J. Impact of mating type, serotype, and ploidy on the virulence of Cryptococcus neoformans. Infect Immun 2008; 76: 2923-38. doi:10.1128/IAI.00168-08.
23. Okabayashi K, Kano R, Watanabe T, Hasegawa A. Serotypes and mating types of clinical isolates from feline cryptococcosis in Japan. J Vet Med Sci 2006; 68: 91-4.
24. D'Souza CA, Hagen F, Boekhout T, Cox GM, Heitman J. Investigation of the basis of virulence in serotype A strains of Cryptococcus neoformans from apparently immunocompetent individuals. Curr Genet 2004; 46: 92-102. doi:10.1007/s00294-004-0511-y.
25. Chaturvedi S, Rodeghier B, Fan J, McClelland CM, Wickes BL, Chaturvedi V. Direct PCR of Cryptococcus neoformans MATalpha and MATa pheromones to determine mating type, ploidy, and variety: a tool for epidemiological and molecular pathogenesis studies. J Clin Microbiol 2000; 38: 2007-9.
26. Escandon P, Quintero E, Granados D, Huerfano S, Ruiz A, Castaneda E. Isolation of Cryptococcus gattii serotype B from detritus of Eucalyptus trees in Colombia. Biomedica 2005; 25: 390-7.
27. Zaragoza O, Fries BC, Casadevall A. Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2). Infect Immun 2003; 71: 6155-64.
28. Pukkila-Worley R, Gerrald QD, Kraus PR et al. Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade. Eukaryot Cell 2005; 4: 190-201. doi:10.1128/EC.4.1.190-201.2005.
29. Chen SC, Wright LC, Santangelo RT et al. Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun 1997; 65: 405-11.
30. CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition, CLSI document M27-A3.: Clinical and Laboratory Standards Institute, Way≠ 2008.
31. De Bedout C, Ordonez N, Gomez BL et al. In vitro antifungal susceptibility of clinical isolates of Cryptococcus neoformans var. neoformans and C. neoformans var. gattii. Rev Iberoam Micol 1999; 16: 36-9.
32. Sarosi GA, Silberfarb PM, Tosh FE. Cutaneous cryptococcosis. A sentinel of disseminated disease. Arch Dermatol 1971; 104: 1-3.
33. Negroni R. Cryptococcosis. Clin Dermatol 2012; 30: 599-609. doi:10.1016/j.clindermatol.2012.01.005.
34. Marques SA, Bastazini I Jr, Martins AL et al. Primary cutaneous cryptococcosis in Brazil: report of 11 cases in immunocompetent and immunosuppressed patients. Int J Dermatol. 2012; 51: 780-4. doi:10.1111/j.1365-4632.2011.05298.x.
35. Riddell RJ, Entwisle BR. Cryptococcal granulomata of the skin in a patient with pulmonary and cerebral cryptococcosis. Australas J Dermatol 1969; 10: 100-8.
36. Severo LC, Berta EZI, Londero AT. Cutaneous cryptococcosis due to Cryptococcus neoformans var. gattii. Rev Iberoam Micol. 2001; 18: 200-1.
37. Xiujiao X, Ai'e X. Two cases of cutaneous cryptococcosis. Mycoses 2005; 48: 238-41. doi:10.1111/j.1439-0507.2005.01079.x.
38. Dora JM, Kelbert S, Deutschendorf C et al. Cutaneous cryptococccosis due to Cryptococcus gattii in immunocompetent hosts: case report and review. Mycopathologia 2006; 161: 235-8. doi:10.1007/s11046-006-0277-5.
39. Tilak R, Prakash P, Nigam C, Tilak V, Gambhir IS, Gulati AK. Cryptococcal meningitis with an antecedent cutaneous Cryptococcal lesion. Dermatol Online J 2009; 15: 12.
40. Hamann ID, Gillespie RJ, Ferguson JK. Primary cryptococcal cellulitis caused by Cryptococcus neoformans var. gattii in an immunocompetent host. Australas J Dermatol 1997; 38: 29-32.
41. Lacaz Cda S, Heins-Vaccari EM, Hernandez-Arriagada GL et al. Primary cutaneous cryptococcosis due to Cryptococcus neoformans var. gattii serotype B, in an immunocompetent patient. Rev Inst Med Trop Sao Paulo 2002; 44: 225-8.
42. Leao CA, Ferreira-Paim K, Andrade-Silva L et al. Primary cutaneous cryptococcosis caused by Cryptococcus gattii in an immunocompetent host. Med Mycol 2011; 49: 352-5. doi:10.3109/13693786.2010.530697.
43. Pasa CR, Chang MR, Hans-Filho G. Post-trauma primary cutaneous cryptococcosis in an immunocompetent host by Cryptococcus gattii VGII. Mycoses 2012; 55: e1-3. doi:10.1111/j.1439-0507.2011.02058.x.
44. Lingegowda BP, Koh TH, Ong HS, Tan TT. Primary cutaneous cryptococcosis due to Cryptococcus gattii in Singapore. Singapore Med J 2011; 52: e160-2.
45. Meyer WT. L. Genotyping of the Cryptococcus neoformans/C. gattii species complex. Australian. Biochemist. 2010; 41: 5.
46. Cogliati M. Global Molecular Epidemiology of Cryptococcus neoformans and Cryptococcus gattii: An atlas of the molecular types. Hindawi Publishing Corporation Scientifica 2013; 2013: 1-23.
47. Trilles L, Lazera Mdos S, Wanke B et al. Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil. Mem Inst Oswaldo Cruz 2008; 103: 455-62.
48. Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun 1994; 62: 1507-12.
49. Fromtling RA, Shadomy HJ, Jacobson ES. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans. Mycopathologia 1982; 79: 23-9.
50. Nosanchuk JD, Valadon P, Feldmesser M, Casadevall A. Melanization of Cryptococcus neoformans in murine infection. Mol Cell Biol 1999; 19: 745-50.
51. Rosas AL, Nosanchuk JD, Feldmesser M, Cox GM, McDade HC, Casadevall A. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents. Infect Immun 2000; 68: 2845-53.
52. Abegg MA, Cella FL, Faganello J, Valente P, Schrank A, Vainstein MH. Cryptococcus neoformans and Cryptococcus gattii isolated from the excreta of psittaciformes in a southern Brazilian zoological garden. Mycopathologia 2006; 161: 83-91. doi:10.1007/s11046-005-0186-z.
53. Karkowska-Kuleta J, Rapala-Kozik M, Kozik A. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Acta Biochim Pol 2009; 56: 211-24.
54. Byrnes EJ III, Bartlett KH, Perfect JR, Heitman J. Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect 2011; 13: 895-907. doi:10.1016/j.micinf.2011.05.009.
55. Espinel-Ingroff A, Aller AI, Canton E et al. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother 2012; 56: 5898-906. doi:10.1128/AAC.01115-12.
56. Pedroso RS, Ferreira JC, Lavrador MA, Maffei CM, Candido RC. Evaluation of the experimental inoculation of Cryptococcus albidus and Cryptococcus laurentii in normal mice: virulence factors and molecular profile before and after animal passage. Mycopathologia 2009; 168: 59-72. doi:10.1007/s11046-009-9202-z.